Ultra-Efficient PrP Amplification Highlights Potentialities and Pitfalls of PMCA Technology

English version České info

In order to investigate the potential of voles to reproduce in vitro the efficiency of prion replication previously observed in vivo, we seeded protein misfolding cyclic amplification (PMCA) reactions with either rodent-adapted Transmissible Spongiform Encephalopathy (TSE) strains or natural TSE isolates. Vole brain homogenates were shown to be a powerful substrate for both homologous or heterologous PMCA, sustaining the efficient amplification of prions from all the prion sources tested. However, after a few serial automated PMCA (saPMCA) rounds, we also observed the appearance of PK-resistant PrP^Sc in samples containing exclusively unseeded substrate (negative controls), suggesting the possible spontaneous generation of infectious prions during PMCA reactions. As we could not definitively rule out cross-contamination through a posteriori biochemical and biological analyses of de novo generated prions, we decided to replicate the experiments in a different laboratory. Under rigorous prion-free conditions, we did not observe de novo appearance of PrP^Sc in unseeded samples of M109M and I109I vole substrates, even after many consecutive rounds of saPMCA and working in different PMCA settings. Furthermore, when positive and negative samples were processed together, the appearance of spurious PrP^Sc in unseeded negative controls suggested that the most likely explanation for the appearance of de novo PrP^Sc was the occurrence of cross-contamination during saPMCA. Careful analysis of the PMCA process allowed us to identify critical points which are potentially responsible for contamination events. Appropriate technical improvements made it possible to overcome PMCA pitfalls, allowing PrP^Sc to be reliably amplified up to extremely low dilutions of infected brain homogenate without any false positive results even after many consecutive rounds. Our findings underline the potential drawback of ultrasensitive in vitro prion replication and warn on cautious interpretation when assessing the spontaneous appearance of prions in vitro.

Vyšlo v časopise: Ultra-Efficient PrP Amplification Highlights Potentialities and Pitfalls of PMCA Technology. PLoS Pathog 7(11): e32767. doi:10.1371/journal.ppat.1002370
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002370

Souhrn

Zdroje

1. PrusinerSB 1998 Prions. Proc Natl Acad Sci U S A 95 13363 83

2. WeissmannC 1991 A 'unified theory' of prion propagation. Nature 352 679 83

3. DickinsonAGOutramGW 1988 Genetic aspects of unconventional virus infections: the basis of the virino hypothesis. Ciba Found Symp 135 63 83

4. DeleaultNRHarrisBTReesJRSupattaponeS 2007 Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 104 9741 6

5. LegnameGBaskakovIVNguyenHORiesnerDCohenFE 2004 Synthetic mammalian prions. Science 305 673 6

6. WangFWangXYuanCGMaJ 2010 Generating a prion with bacterially expressed recombinant prion protein. Science 327 1132 1135

7. MakaravaNKovacsGGBocharovaOSavtchenkoRAlexeevaI 2010 Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 119 177 87

8. KimJICaliISurewiczKKongQRaymondGJ 2010 Mammalian prions generated from bacterially expressed prion protein in the absence of any mammalian cofactors. J Biol Chem 285 14083 7

9. BarronRMCampbellSLKingDBellonAChapmanKE 2007 High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 282 35878 86

10. CaugheyBRaymondGJErnstDRaceRE 1991 N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol 65 6597 603

11. PanKMBaldwinMNguyenJGassetMSerbanA 1993 Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 90 10962 6

12. GajdusekDC 1988 Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to beta-pleated sheet configurations. J Neuroimmunol 20 95 110

13. CollingeJSidleKCMeadsJIronsideJHillAF 1996 Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383 685 90

14. BruceMEWillRGIronsideJWMcConnellIDrummondD 1997 Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389 498 501

15. LasmézasCIDeslysJPDemaimayRAdjouKTLamouryF 1996 BSE transmission to macaques. Nature 381 743 4

16. GilliesMChohanGLlewelynCAMacKenzieJWardHJ 2009 A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions. Vox Sang 97 211 8

17. SaborioGPPermanneBSotoC 2001 Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411 810 3

18. CastillaJSaáPHetzCSotoC 2005 In vitro generation of infectious scrapie prions. Cell 121 195 206

19. CastillaJMoralesRSaáPBarriaMGambettiP 2008 Cell-free propagation of prion strains. EMBO J 27 2557 66

20. GreenKMCastillaJSewardTSNapierDLJewellJE 2008 Accelerated high fidelity prion amplification within and across prion species barriers. PLoS Pathog 4 e1000139

21. CastillaJGonzalez-RomeroDSaáPMoralesRDe CastroJ 2008 Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134 757 68

22. SaáPCastillaJSotoC 2006 Presymptomatic detection of prions in blood. Science 313 92 4

23. CastillaJSaáPSotoC 2005 Detection of prions in blood. Nat Med 11 982 5

24. Gonzalez-RomeroDBarriaMALeonPMoralesRSotoC 2008 Detection of infectious prions in urine. FEBS Lett 582 3161 6

25. SaaPCastillaJSotoC 2006 Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 281 35245 52

26. ThorneLTerryLA 2008 In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89 3177 84

27. BarriaMAMukherjeeAGonzalez-RomeroDMoralesRSotoC 2009 De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog 5 e1000421

28. NonnoRDi BariMACardoneFVaccariGFazziP 2006 Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog 2 e12

29. AgrimiUNonnoRDell'OmoGDi BariMAConteM 2008 Prion protein amino acid determinants of differential susceptibility and molecular feature of prion strains in mice and voles. PLoS Pathog 4 e1000113

30. Di BariMAChianiniFVaccariGEspositoEConteM 2008 The bank vole (Myodes glareolus) as a sensitive bioassay for sheep scrapie. J Gen Virol 89 2975 85

31. CartoniCSchininàMEMarasBNonnoRVaccariG 2005 Identification of the pathological prion protein allotypes in scrapie-infected heterozygous bank voles (Clethrionomys glareolus) by high-performance liquid chromatography-mass spectrometry. J Chromatogr 1081 122 6

32. SigurdsonCJNilssonKPHornemannSHeikenwalderMMancoG 2009 De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci U S A 106 304 9

33. EdgeworthJAGrosNAldenJJoinerSWadsworthJD 2010 Spontaneous generation of mammalian prions. Proc Natl Acad Sci U S A 107 14402 6

34. BruceME 1993 Scrapie strain variation and mutation. Br Med Bull 49 822 38

35. CastillaJGonzalez-RomeroDSaáPMoralesRDe CastroJ 2008 Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134 757 68

36. ColbyDWZhangQWangSGrothDLegnameG 2007 Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A 104 20914 9

37. MurayamaYYoshiokaMYokoyamaTIwamaruYImamuraM 2007 Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci Lett 413 270 3

38. Gonzalez-MontalbanNMakaravaNOstapchenkoVGSavtchenkRAlexeevaI 2011 Highly efficient protein misfolding cyclic amplification. PLoS Pathog 7 e1001277